caffeine has been researched along with oxazolidin-2-one in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dixon, RM; Evans, DH; Meire, HB; On, N; Posner, J; Rolan, PE; Watt, H | 1 |
Jung, S | 1 |
Calo', G; Camarda, V; Ciccocioppo, R; Cifani, C; Filaferro, M; Guerrini, R; Pela', M; Reinscheid, RK; Rizzi, A; Ruggieri, V; Ruzza, C; Salvadori, S; Trapella, C; Vitale, G | 1 |
1 trial(s) available for caffeine and oxazolidin-2-one
Article | Year |
---|---|
Peripheral vascular effects and pharmacokinetics of the antimigraine compound, zolmitriptan, in combination with oral ergotamine in healthy volunteers.
Topics: Administration, Oral; Adult; Biological Availability; Blood Pressure; Caffeine; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Ergotamine; Female; Humans; Intestinal Absorption; Male; Oxazoles; Oxazolidinones; Pulse; Reference Values; Serotonin Receptor Agonists; Tryptamines; Vasoconstrictor Agents | 1997 |
2 other study(ies) available for caffeine and oxazolidin-2-one
Article | Year |
---|---|
The impact of migraine: a case study.
Topics: Acupuncture Therapy; Administration, Rectal; Adult; Caffeine; Combined Modality Therapy; Drug Combinations; Ergotamine; Fructose; Humans; Male; Manipulation, Chiropractic; Middle Aged; Migraine Disorders; Neuroprotective Agents; Oxazolidinones; Serotonin Receptor Agonists; Severity of Illness Index; Topiramate; Tryptamines; Vasoconstrictor Agents | 2007 |
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Caffeine; Cell Line; Eating; Exploratory Behavior; Humans; Male; Maze Learning; Mice; Motor Activity; Neuropeptides; Oxazolidinones; Pyrazines; Rats; Receptors, Neuropeptide | 2010 |